STADA Arzneimittel Acquired by CapVest | Healthcare M&A Deal

CapVest has completed the acquisition of STADA Arzneimittel, a pharmacy business in Germany, for over $100M. STADA Arzneimittel operates in specialty pharmaceuticals and generics, supplying healthcare products across multiple European markets. CapVest acquires STADA Arzneimittel to expand its healthcare M&A platform and deepen exposure to prescription and consumer health categories. The STADA Arzneimittel acquisition is a platform acquisition led by private equity, supporting CapVest acquisitions in the pharmacy acquisition segment.